Compare GRFS & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | JXN |
|---|---|---|
| Founded | 1940 | 1961 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.5B |
| IPO Year | 2006 | N/A |
| Metric | GRFS | JXN |
|---|---|---|
| Price | $8.92 | $98.29 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $10.30 | ★ $108.80 |
| AVG Volume (30 Days) | ★ 667.0K | 539.3K |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | 1.60% | ★ 3.26% |
| EPS Growth | N/A | N/A |
| EPS | 0.64 | ★ 7.31 |
| Revenue | ★ $8,821,017,248.00 | $4,997,000,000.00 |
| Revenue This Year | $5.46 | $116.66 |
| Revenue Next Year | $5.60 | $5.25 |
| P/E Ratio | $17.34 | ★ $13.43 |
| Revenue Growth | 7.31 | ★ 25.33 |
| 52 Week Low | $6.19 | $64.70 |
| 52 Week High | $11.14 | $104.62 |
| Indicator | GRFS | JXN |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 55.14 |
| Support Level | $7.64 | $97.36 |
| Resistance Level | $8.90 | $100.32 |
| Average True Range (ATR) | 0.27 | 2.48 |
| MACD | 0.07 | 0.72 |
| Stochastic Oscillator | 92.00 | 78.97 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.